Chloe Botaine

Voluntary industry codes of conduct allow the Federal Trade Commission to prosecute companies for deceptive practices if they fail to uphold their public privacy attestations. This regulatory mechanism currently serves as a primary line of defense for millions of Americans using fitness trackers,

Citius Pharmaceuticals is leveraging a staggering 86 percent overall response rate from Phase 1 trials of LYMPHIR as a pretreatment for CAR-T therapy in large B-cell lymphoma. This clinical success arrives at a pivotal moment as the company navigates the complex transition from a research-oriented

Medical device seizures and withdrawals are often caused by preventable labeling errors, making senior-level regulatory judgment an essential part of the compliance process. The transition from the old regulatory framework to the current European Union Medical Device Regulation (EU MDR) has

The Google Health Coach functions as a digital concierge, allowing U.S. users to sync their medical records and search for specialized healthcare providers across 200 different fields. This innovation stems from a landmark multiyear partnership between Abbott and Google, specifically designed to

The transition from active medical treatment to long-term monitoring is becoming a financial hurdle for survivors who face monthly insurance cost increases of $300 or more. This reality is part of a broader, more systemic crisis where millions of Americans find themselves navigating an increasingly

James Maitland is a pioneering figure in the integration of robotics and the Internet of Things within the medical landscape. With a career dedicated to bridging the often-overlooked gap between high-tech innovation and bedside application, he offers a unique perspective on how large-scale funding

The rapid evolution of biosensors and non-invasive monitoring tools has fundamentally transformed how healthcare providers approach chronic disease management and patient recovery. As 2026 begins, the Government Accountability Office has identified critical policy gaps that hinder the full

Clinical environments across the globe are currently witnessing a seismic shift where algorithmic precision is no longer a luxury but a fundamental component of patient care. In the span of just a few years, the integration of artificial intelligence into medical devices has transitioned from

The European healthcare technology investment landscape is no longer defined by the speculative frenzy that characterized the early part of the decade, shifting instead toward a disciplined philosophy known as the Great Rationalization. In the earlier years of this decade, capital was often

James Maitland is a leading voice in the evolution of health technology, specializing in the intersection of robotics and IoT applications within modern medicine. With a career dedicated to transforming complex data into actionable lifestyle changes, Maitland has seen firsthand how wearable